Use of Parathyroid Function Index and Wisconsin Index to Differentiate Primary Hyperparathyroidism From Secondary Hyperparathyroidism: A Case-Control Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Apr 14

PMID 35419240

Authors

Murat Bulut Ozkan

Veysel Baris Turhan

Affiliations

Soon will be listed here.

Abstract

Introduction: Patients with primary hyperparathyroidism (PHPT) can be asymptomatic or have a normal calcium level (NHPT). Patients with 25(OH) vitamin D insufficiency, on the other hand, may present with a similar presentation. In regions where 25(OH) vitamin D deficiency is common, patients are usually diagnosed with secondary hyperparathyroidism (SHPT). Therefore, it is necessary to separate PHPT and NHPT from SHPT. Parathormone and calcium values are used for differentiation in the clinic. The predictive value of the newly developed parathyroid function test (PFindex), which previously had a high diagnostic value, was evaluated in this patient population in our investigation.

Methods: The study comprised 163 PHPT and NHPT patients with pathological confirmation and 56 SHPT patients. The PHPT, NHPT, and SHPT properties were defined using PFindex. The diagnostic power of PFindex was investigated using a receiver operating characteristic (ROC) curve of the results assessed in three groups.

Results: The PHPT group had the highest PFindex (1365.4±784.6) compared to the other two groups (NHPT: 723.5±509.4; SHPT:227.2±49.9, all p < 0.001). A PFindex threshold of 327.8 yielded 91.9% and 90.9% sensitivity and specificity rates for distinguishing PHPT and NHPT from SHPT, respectively.

Conclusion: PFindex gave the outstanding diagnostic capacity to distinguish PHPT from SHPT due to our research. This straightforward tool can assist in making quick decisions about vitamin D therapy or surgery for PHPT.

Citing Articles

Assessment of Vitamin D Status in Primary Hyperparathyroidism Patients: A Retrospective Study.

Kolcsar M, Szabo L, Denes O, Gall Z Cureus. 2024; 16(7):e64988.

PMID: 39040613 PMC: 11260692. DOI: 10.7759/cureus.64988.

References

Oberger Marques J, Moreira C . Primary hyperparathyroidism. Best Pract Res Clin Rheumatol. 2020; 34(3):101514. DOI: 10.1016/j.berh.2020.101514. View

Eastell R, Brandi M, Costa A, DAmour P, Shoback D, Thakker R . Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014; 99(10):3570-9. DOI: 10.1210/jc.2014-1414. View

Mazeh H, Chen H, Leverson G, Sippel R . Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg. 2012; 257(1):138-41. DOI: 10.1097/SLA.0b013e31825ffbe1. View

Wermers R, Khosla S, Atkinson E, Achenbach S, Oberg A, Grant C . Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2005; 21(1):171-7. DOI: 10.1359/JBMR.050910. View

Cho Y, Kim J, Shim J, Yang H, Chang J, Moon J . Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population. Pediatr Gastroenterol Hepatol Nutr. 2019; 22(3):233-241. PMC: 6506433. DOI: 10.5223/pghn.2019.22.3.233. View

Serradilla-Martin M, Palomares-Cano A, Cantalejo-Diaz M, Mogollon-Gonzalez M, Brea-Gomez E, Munoz-Perez N . Usefulness of the Wisconsin and CaPTHUS indices for predicting multiglandular disease in patients with primary hyperparathyroidism in a southern European population. Gland Surg. 2021; 10(3):861-869. PMC: 8033049. DOI: 10.21037/gs-20-857. View

Dai J, He P, Chen X, Greenfield E . TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics. Bone. 2005; 38(4):509-20. DOI: 10.1016/j.bone.2005.10.007. View

Holick M . The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017; 18(2):153-165. DOI: 10.1007/s11154-017-9424-1. View

Madeo B, Kara E, Cioni K, Vezzani S, Trenti T, Santi D . Serum Calcium to Phosphorous (Ca/P) Ratio Is a Simple, Inexpensive, and Accurate Tool in the Diagnosis of Primary Hyperparathyroidism. JBMR Plus. 2018; 2(2):109-117. PMC: 6124174. DOI: 10.1002/jbm4.10019. View

10.

Arya A, Kumari P, Bhadada S, Agrawal K, Singh P, Mukherjee S . Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. J Bone Miner Metab. 2020; 39(2):253-259. DOI: 10.1007/s00774-020-01142-w. View

11.

Bilezikian J, Bandeira L, Khan A, Cusano N . Hyperparathyroidism. Lancet. 2017; 391(10116):168-178. DOI: 10.1016/S0140-6736(17)31430-7. View

12.

McKenna M . Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992; 93(1):69-77. DOI: 10.1016/0002-9343(92)90682-2. View

13.

Griebeler M, Kearns A, Ryu E, Hathcock M, Melton 3rd L, Wermers R . Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2014; 73:1-7. PMC: 4445941. DOI: 10.1016/j.bone.2014.12.003. View

14.

Hatun S, Ozkan B, Bereket A . Vitamin D deficiency and prevention: Turkish experience. Acta Paediatr. 2011; 100(9):1195-9. DOI: 10.1111/j.1651-2227.2011.02383.x. View

15.

CHAPUY M, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S . Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997; 7(5):439-43. DOI: 10.1007/s001980050030. View

16.

Walker M, Silverberg S . Primary hyperparathyroidism. Nat Rev Endocrinol. 2017; 14(2):115-125. PMC: 6037987. DOI: 10.1038/nrendo.2017.104. View

17.

Madeo B, De Vincentis S, Repaci A, Altieri P, Vicennati V, Kara E . The calcium-to-phosphorous (Ca/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study. Endocrine. 2020; 68(3):679-687. DOI: 10.1007/s12020-020-02276-7. View

18.

De Pasquale L, Lori E, Bulfamante A, Felisati G, Castellani L, Saibene A . Evaluation of Wisconsin and CaPTHUS Indices Usefulness for Predicting Monoglandular and Multiglandular Disease in Patients with Primary Hyperparathyroidism through the Analysis of a Single-Center Experience. Int J Endocrinol. 2021; 2021:2040284. PMC: 8523259. DOI: 10.1155/2021/2040284. View

19.

Madeo B, De Vincentis S, Kara E, Vescini F, Trenti T, Guaraldi G . Reliability of calcium-phosphorus (Ca/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders. J Endocrinol Invest. 2019; 42(9):1041-1049. DOI: 10.1007/s40618-019-01025-6. View

20.

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View